Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis
暂无分享,去创建一个
A. Ogdie | J. Baker | T. Mikuls | M. George | B. Sauer | B. England | G. Cannon | Carlos D. Hunter | Bartlett C. Hamilton | M. Duryee | Geoffrey E. Thiele
[1] Seoyoung C. Kim,et al. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population‐Based Cohort Study , 2020, Arthritis care & research.
[2] M. Hochberg,et al. Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis , 2019, PloS one.
[3] M. Kratz,et al. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. , 2018, Comprehensive Physiology.
[4] G. Guggino,et al. The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and Diabetes. , 2018, Reviews on recent clinical trials.
[5] P. Libby,et al. Anti-Inflammatory Therapy With Canakinumab for the Prevention and Management of Diabetes. , 2018, Journal of the American College of Cardiology.
[6] G. Booth,et al. Identifying diabetes cases from administrative data: a population-based validation study , 2018, BMC Health Services Research.
[7] K. Levin,et al. Patients with newly diagnosed rheumatoid arthritis are at increased risk of diabetes mellitus: an observational cohort study. , 2017, Acta reumatologica portuguesa.
[8] O. Vittecoq,et al. Rheumatoid arthritis, insulin resistance, and diabetes. , 2017, Joint, bone, spine : revue du rhumatisme.
[9] C. Ballantyne,et al. Skeletal muscle inflammation and insulin resistance in obesity , 2017, The Journal of clinical investigation.
[10] Chenxiao Liu,et al. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. , 2016, Cytokine.
[11] Jaw-Wen Chen,et al. Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes? , 2016, Cardiovascular Diabetology.
[12] J. Žibert,et al. Methotrexate reduces HbA1c concentration but does not produce chronic accumulation of ZMP in patients with rheumatoid or psoriatic arthritis , 2016, Scandinavian journal of rheumatology.
[13] M. Hochberg,et al. Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events , 2015, Arthritis & rheumatology.
[14] S. Legrand-Poels,et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. , 2014, Diabetes research and clinical practice.
[15] R. Wolff,et al. Cardiovascular Events Are Not Associated with MTHFR Polymorphisms, But Are Associated with Methotrexate Use and Traditional Risk Factors in US Veterans with Rheumatoid Arthritis , 2013, The Journal of Rheumatology.
[16] Andre Pascal Kengne,et al. Diabetes Mellitus and Inflammation , 2013, Current Diabetes Reports.
[17] H. Sayles,et al. Prospective study of posttraumatic stress disorder and disease activity outcomes in US veterans with rheumatoid arthritis , 2013, Arthritis care & research.
[18] A. Reimold,et al. Adherence with bisphosphonate therapy in US veterans with rheumatoid arthritis , 2012, Arthritis care & research.
[19] A. Reimold,et al. Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practice , 2011, Arthritis care & research.
[20] J. Singh,et al. Derivation and preliminary validation of an administrative claims-based algorithm for the effectiveness of medications for rheumatoid arthritis , 2011, Arthritis research & therapy.
[21] S. Schneeweiss,et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. , 2011, JAMA.
[22] P. Gregersen,et al. Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione s-transferase in a cross-sectional study , 2010, Arthritis Research & Therapy.
[23] W. Dixon,et al. A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries. , 2010, Seminars in arthritis and rheumatism.
[24] S. Schneeweiss,et al. Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis , 2010, Annals of the rheumatic diseases.
[25] K. Michaud,et al. Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis , 2010, Annals of the rheumatic diseases.
[26] D. Chisholm,et al. Subcutaneous and Visceral Adipose Tissue Gene Expression of Serum Adipokines That Predict Type 2 Diabetes , 2010, Obesity.
[27] L. Espinoza,et al. Does TNF-alpha blockade play any role in cardiovascular risk among rheumatoid arthritis (RA) patients? , 2009, Clinical Rheumatology.
[28] J. Eckel,et al. Monocyte chemotactic protein-1 and its role in insulin resistance , 2007, Current opinion in lipidology.
[29] C. Meisinger,et al. Chemokines as risk factors for type 2 diabetes: results from the MONICA/KORA Augsburg study, 1984–2002 , 2006, Diabetologia.
[30] W. März,et al. Association between the A–2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus , 2004, Diabetologia.
[31] Joachim Spranger,et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. , 2003, Diabetes.
[32] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[33] P. Jiang,et al. Diabetes mellitus risk factors in rheumatoid arthritis: a systematic review and meta-analysis. , 2015, Clinical and experimental rheumatology.
[34] Brian T Fay,et al. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. , 2011, Rheumatology.
[35] R. Yu,et al. Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6. , 2005, Diabetes research and clinical practice.
[36] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.